Prime Medicine

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Prime Medicine and other ETFs, options, and stocks.

About PRME

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. 

CEO
Allan Jacob Reine
CEOAllan Jacob Reine
Employees
214
Employees214
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2019
Founded2019
Employees
214
Employees214

PRME Key Statistics

Market cap
832.18M
Market cap832.18M
Price-Earnings ratio
-2.92
Price-Earnings ratio-2.92
Dividend yield
—
Dividend yield—
Average volume
3.09M
Average volume3.09M
High today
$5.39
High today$5.39
Low today
$3.96
Low today$3.96
Open price
$3.96
Open price$3.96
Volume
5.13M
Volume5.13M
52 Week high
$5.39
52 Week high$5.39
52 Week low
$1.11
52 Week low$1.11

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own PRME. This list is generated using Robinhood data, and it’s not a recommendation.
Intellia Therapeutics
Rocket Lab Corporation
Archer Aviation
Beam Therapeutics
IonQ
CRISPR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.